Nitrofurantoin switch on New Zealand agenda

19 February 2015 - Deborah Wilkes


Switching nitrofurantoin from prescription to non-prescription status for treating cystitis is on the agenda in New Zealand. The country is also set to consider potential safety issues involving omeprazole and combinations of paracetamol with phenylephrine.

Click tags below for more information on topics:

Medsafe Bilastine

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: